Go Deep
Organo Corporation
Organo Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,803 | 19.0 | 3.68 | 0.26 | 1,383.86 |
| Oct 2026 | 23,101 | 18.6 | 3.68 | 0.26 | 1,381.52 |
| Oct 2026 | 22,929 | 19.3 | 3.81 | 0.26 | 1,431.97 |
| Oct 2026 | 23,048 | 18.9 | 3.72 | 0.26 | 1,393.68 |
Organo Corporation Quarterly Results
| Line Item | Jun 2026 | Jun 2025 |
|---|---|---|
| EPS | 14.9 | 15.8 |
Organo Corporation Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 177,654,000,000.0 | 163,269,000,000.0 | 150,356,000,000.0 | 132,426,000,000.0 |
| Net Profit | 28,401,000,000.0 | 24,150,000,000.0 | 17,310,000,000.0 | 11,730,000,000.0 |
| EPS | 123.5 | 105.1 | 75.4 | 51.2 |
Organo Corporation Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 224,867,000,000.0 | 194,396,000,000.0 | 182,703,000,000.0 | 164,854,000,000.0 | — |
| Total Liabilities | 81,906,000,000.0 | 73,203,000,000.0 | 80,557,000,000.0 | 78,484,000,000.0 | — |
| Total Equity | 142,961,000,000.0 | 120,947,000,000.0 | 101,927,000,000.0 | 86,169,000,000.0 | — |
Owes vs Owns
Organo Corporation owed ¥0.36 for every ¥1 it owned in Mar 2026, down from ¥0.48 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.36× | 0.38× | 0.44× | 0.48× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Organo Corporation Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 37.8%Receivables 21.3%Inventory 8.3%Fixed assets (tangible) 10.0%Intangible assets 0.7%Long-term investments 1.2%Other assets 20.8%
How it's funded — Mar 2026
Short-term debt 12.6%Long-term debt 2.7%Payables 8.9%Other liabilities 12.3%Shareholders' equity 63.6%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 84,911.0 | 52,263.0 | 45,456.0 | 25,411.0 |
| Receivables | 47,989.0 | 43,226.0 | 44,121.0 | 40,496.0 |
| Inventory | 18,563.0 | 22,524.0 | 21,830.0 | 30,795.0 |
| Fixed assets (tangible) | 22,402.0 | 21,516.0 | 20,634.0 | 20,795.0 |
| Intangible assets | 1,572.0 | 1,120.0 | 986.0 | 949.0 |
| Long-term investments | 2,723.0 | 2,373.0 | 2,835.0 | 2,430.0 |
| Other assets | 46,707.0 | 51,374.0 | 46,841.0 | 43,978.0 |
| Liabilities & equity | ||||
| Short-term debt | 28,402.0 | 18,877.0 | 34,065.0 | 29,124.0 |
| Long-term debt | 6,000.0 | 3,680.0 | 2,400.0 | 3,895.0 |
| Payables | 19,953.0 | 23,438.0 | 19,842.0 | 20,904.0 |
| Other liabilities | 27,551.0 | 27,208.0 | 24,250.0 | 24,561.0 |
| Shareholders' equity | 142,961.0 | 121,193.0 | 102,146.0 | 86,370.0 |
| Net tangible assets | 141,389.0 | 119,827.0 | 100,941.0 | 85,220.0 |
Organo Corporation Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 13,099,000,000.0 | 21,100,000,000.0 | 3,726,000,000.0 | -18,536,000,000.0 | — |
| Investing Activities | -2,743,000,000.0 | -2,130,000,000.0 | -1,415,000,000.0 | -1,309,000,000.0 | — |
| Financing Activities | 3,118,000,000.0 | -20,821,000,000.0 | -641,000,000.0 | 14,706,000,000.0 | — |